findmyKOL

Scott Newsome, DO

Enriched profile

Professor of Clinical Neurology · Johns Hopkins University School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyNeurologyFocusMultiple Sclerosis Research Studies+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2026–2026

Scott Newsome is Professor of Clinical Neurology at Johns Hopkins University School of Medicine. OpenAlex indexes 289 publications with 9,219 citations (h-index 43); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 14 Sept 2026

Overview

Updated 16 Oct 2026

Scott D. Newsome, DO, is Professor of Clinical Neurology at Johns Hopkins University School of Medicine. The public record shows 289 publications with 9,219 citations (h-index 43), centered on Multiple Sclerosis Research Studies, Autoimmune Neurological Disorders and Treatments, Peripheral Neuropathies and Disorders. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 15 companies, 1 NIH-funded awards (2026–2026).

  • Most recent indexed publication: 2026 · Multiple sclerosis (Houndmills, Basingstoke, England)
  • Top research focus: Multiple Sclerosis Research Studies
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 15 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Multiple Sclerosis5 trialsMultiple Sclerosis, Chronic Progressive1 trial

Research focus

OpenAlex concept fingerprint
Multiple Sclerosis Research StudiesAutoimmune Neurological Disorders and TreatmentsPeripheral Neuropathies and DisordersGenetic Neurodegenerative DiseasesNeurological and metabolic disorders

Drugs & molecules

across trials, industry payments and publications
Ocrevusgeneric · OcrelizumabClinical trials—Industry payments54Publications1Briumvigeneric · UblituximabClinical trials—Industry payments8Publications—Kesimptageneric · OfatumumabClinical trials—Industry payments4Publications—Upliznageneric · InebilizumabClinical trials—Industry payments4Publications—Ensprynggeneric · SatralizumabClinical trials—Industry payments2Publications—Ocrevus Zunovogeneric · Hyaluronidase / ocrelizumabClinical trials—Industry payments2Publications—Plegridygeneric · Peginterferon beta-1aClinical trials—Industry payments2Publications—Avonexgeneric · Interferon beta-1aClinical trials—Industry payments1Publications—EvobrutinibClinical trials—Industry payments1Publications—Mavencladgeneric · CladribineClinical trials—Industry payments1Publications—Tecfiderageneric · Dimethyl fumarateClinical trials—Industry payments1Publications—Tysabrigeneric · NatalizumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Genentech USA, Inc.Clinical trials—Industry payments42Genentech, Inc.Clinical trials—Industry payments11Genzyme CorporationClinical trials—Industry payments11Tg Therapeutics, Inc.Clinical trials—Industry payments9F. Hoffmann-La Roche AGClinical trials—Industry payments7EMD Serono, Inc.Clinical trials—Industry payments5Johns Hopkins UniversityClinical trials5Industry payments—Biogen, Inc.Clinical trials—Industry payments4Horizon Therapeutics plcClinical trials—Industry payments4Novartis Pharmaceuticals CorporationClinical trials—Industry payments3Roche Products LimitedClinical trials—Industry payments2Celgene CorporationClinical trials—Industry payments1E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Jazz Pharmaceuticals Inc.Clinical trials—Industry payments1Novartis Pharma AGClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
289publications

Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.

9,219citations

Total citations across indexed works.

43h-index

Hirsch index (OpenAlex). i10-index 98.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
15companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2026–2026

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record
  • Director

    Johns Hopkins Stiff Person Syndrome Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Director

    Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Director

    Johns Hopkins Neurosciences Consultation and Infusion Center at Green Spring Station

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Co-Director

    Multiple Sclerosis Experimental Therapeutics Program, Johns Hopkins

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • President of the Board of Governors

    Consortium of Multiple Sclerosis Centers (CMSC)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗
  • Treasurer (former President)

    Consortium of Multiple Sclerosis Centers

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Adviser and committee member

    National Multiple Sclerosis Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Chair

    Consortium of MS Centers Consensus Conference Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    63.4%
    Benzodiazepine34.7%
    Clonazepam50%Diazepam50%
    Part D≥28 patients
    Gabapentinoids15.3%
    Gabapentin73%Pregabalin27%
    Part D<11 patients

    + 5 more classes in this area

  • Musculoskeletal

    21.6%
    gamma-Aminobutyric Acid-ergic Agonist11.4%
    Baclofen100%
    Part D≥23 patients
    Central alpha-2 Adrenergic Agonist7.2%
    Tizanidine Hcl100%
    Part D≥15 patients

    + 1 more class in this area

  • Cancer & immunology

    11%
    CD20-directed Cytolytic Antibody3.6%
    Kesimpta Pen100%
    Part D<11 patients
    Other immunosuppressants3.3%
    Dimethyl Fumarate100%
    Part D<11 patients

    + 3 more classes in this area

All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)47.9% facility · 52.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:

Congress activity

Updated 16 Oct 2026

1 congress contribution (2013) across ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Peter A. Calabresi65Shiv Saidha42Yujie Wang37Ellen M. Mowry35Elias S. Sotirchos26Jerry L. Prince26Elliot M. Frohman25Kathryn C. Fitzgerald24Laura J. Balcer23John N. Ratchford20Jiwon Oh17Daniel S. Reich17Blake E. Dewey17Jennifer Graves17Kathleen M. Zackowski16Danielle Obando15Lianrui Zuo14Scott S. Zamvil14Olwen C. Murphy14Michael Levy14Shuvro Roy13Aaron Carass13June Halper13Teresa C. Frohman13Thomas Shoemaker12Samuel W. Remedios11Maureen A. Mealy10Carlos A. Pardo10Stephanie B. Syc‐Mazurek10Salman Aljarallah10Pavan Bhargava10Ciprian M. Crainiceanu10Serena Hung10Diego Centonze9Carlos Pardo‐Villamizar9Jacqueline Koshorek9Michael Comisac9Douglas L. Arnold9Kathleen Costello9Bernd C. Kieseier9

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/scott-newsome-do

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    realtalkms.com/episode-182-covid-19-vaccine-myth-busting-with-dr-scott-newsome

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →realtalkms.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship (Neuroimmunology/MS)

    Johns Hopkins University School of Medicine

    2009
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Neurology Residency

    Albany Medical Center

    2008
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Board Certified

    Neurology, American Board of Psychiatry and Neurology

    2008
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • DO

    New York Institute of Technology College of Osteopathic Medicine

    2004
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.